Reynoso Jamie L. 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Reynoso Jamie L.（CIK 1839066）在 1 家公司共报告 48 笔 SEC Form 4 内部人交易（最近一笔 2026-10-07）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-10-07 | CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) | CEO, Medicare Advantage | 卖出 | 2,006 | $9,288 |
| 2026-10-05 | CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) | CEO, Medicare Advantage | 卖出 | 8,750 | $38,675 |
| 2026-09-18 | CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) | CEO, Medicare Advantage | 卖出 | 1,921 | $8,760 |
| 2026-09-15 | CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) | CEO, Medicare Advantage | 卖出 | 9,273 | $44,325 |
| 2026-07-17 | CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) | CEO, Medicare Advantage | 卖出 | 4,839 | $21,921 |
| 2026-07-16 | CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) | CEO, Medicare Advantage | 卖出 | 13,119 | $61,266 |
| 2026-07-09 | CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) | CEO, Medicare Advantage | 卖出 | 2,384 | $11,157 |
| 2026-07-06 | CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) | CEO, Medicare Advantage | 卖出 | 6,229 | $32,765 |
| 2026-06-18 | CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) | CEO, Medicare Advantage | 卖出 | 2,360 | $11,281 |
| 2026-06-16 | CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) | CEO, Medicare Advantage | 卖出 | 6,350 | $29,274 |
| 2026-06-11 | CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) | CEO, Medicare Advantage | 卖出 | 7,289 | $35,789 |
| 2026-04-16 | CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) | CEO, Medicare Advantage | 卖出 | 12,712 | $25,932 |
| 2026-04-07 | CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) | CEO, Medicare Advantage | 卖出 | 6,197 | $10,659 |
| 2026-04-03 | CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) | CEO, Medicare Advantage | 买入 | 159,384 | $0 |
| 2026-03-18 | CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) | CEO, Medicare Advantage | 卖出 | 5,833 | $11,141 |
| 2026-03-17 | CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) | CEO, Medicare Advantage | 卖出 | 8,945 | $17,711 |
| 2026-03-17 | CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) | CEO, Medicare Advantage | 卖出 | 6,187 | $12,250 |
| 2026-01-20 | CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) | CEO, Medicare Advantage | 卖出 | 14,732 | $41,397 |
| 2026-01-20 | CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) | CEO, Medicare Advantage | 卖出 | 4,597 | $11,860 |
| 2026-01-07 | CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) | CEO, Medicare Advantage | 卖出 | 2,102 | $5,318 |
| 2026-01-05 | CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) | CEO, Medicare Advantage | 卖出 | 8,109 | $19,543 |
| 2025-12-18 | CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) | CEO, Medicare Advantage | 卖出 | 4,913 | $12,823 |
| 2025-12-16 | CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) | CEO, Medicare Advantage | 卖出 | 12,567 | $33,931 |
| 2025-12-16 | CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) | CEO, Medicare Advantage | 卖出 | 8,691 | $23,466 |
| 2025-11-05 | CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) | CEO, Medicare Advantage | 卖出 | 30,385 | $108,778 |
来源：SEC Form 4 申报文件 · 截至 2026-10-07